Apex Biotechnology Corp. (TPE:1733)

Apex Biotechnology Revenue

Apex Biotechnology had revenue of 519.72M TWD in the quarter ending March 31, 2026, a decrease of -6.99%. This brings the company's revenue in the last twelve months to 1.91B, down -2.78% year-over-year. In the year 2025, Apex Biotechnology had annual revenue of 1.94B with 5.00% growth.

• Revenue (ttm): 1.91B
• Revenue Growth: -2.78%
• P/S Ratio: 1.57
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.99B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.94B	92.70M	5.00%
Dec 31, 2024	1.85B	175.67M	10.48%
Dec 31, 2023	1.68B	-567.64M	-25.29%
Dec 31, 2022	2.24B	112.52M	5.28%
Dec 31, 2021	2.13B	126.32M	6.30%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error